159 related articles for article (PubMed ID: 24184502)
1. Modulation of N-glycosylation by mesalamine facilitates membranous E-cadherin expression in colon epithelial cells.
Khare V; Lang M; Dammann K; Campregher C; Lyakhovich A; Gasche C
Biochem Pharmacol; 2014 Jan; 87(2):312-20. PubMed ID: 24184502
[TBL] [Abstract][Full Text] [Related]
2. Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1.
Khare V; Lyakhovich A; Dammann K; Lang M; Borgmann M; Tichy B; Pospisilova S; Luciani G; Campregher C; Evstatiev R; Pflueger M; Hundsberger H; Gasche C
Biochem Pharmacol; 2013 Jan; 85(2):234-44. PubMed ID: 23146664
[TBL] [Abstract][Full Text] [Related]
3. Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
Bajpai M; Seril DN; Van Gurp J; Geng X; Alvarez J; Minacapelli CD; Gorin S; Das KK; Poplin E; Cheng J; Amenta PS; Das KM
Dig Dis Sci; 2019 Mar; 64(3):740-750. PubMed ID: 30478770
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.
Li J; Chen C; Cao XN; Wang GH; Hu JB; Wang J
J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):59-65. PubMed ID: 24496680
[TBL] [Abstract][Full Text] [Related]
6. Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions.
Pinho SS; Oliveira P; Cabral J; Carvalho S; Huntsman D; Gärtner F; Seruca R; Reis CA; Oliveira C
PLoS One; 2012; 7(3):e33191. PubMed ID: 22427986
[TBL] [Abstract][Full Text] [Related]
7. Mesalamine inhibits epithelial beta-catenin activation in chronic ulcerative colitis.
Brown JB; Lee G; Managlia E; Grimm GR; Dirisina R; Goretsky T; Cheresh P; Blatner NR; Khazaie K; Yang GY; Li L; Barrett TA
Gastroenterology; 2010 Feb; 138(2):595-605, 605.e1-3. PubMed ID: 19879273
[TBL] [Abstract][Full Text] [Related]
8. Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis.
Varga G; Ugocsai M; Hartmann P; Lajkó N; Molnár R; Szűcs S; Jász DK; Érces D; Ghyczy M; Tóth G; Boros M
Inflammopharmacology; 2018 Feb; 26(1):261-271. PubMed ID: 28451776
[TBL] [Abstract][Full Text] [Related]
9. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin.
Pinho SS; Reis CA; Paredes J; Magalhães AM; Ferreira AC; Figueiredo J; Xiaogang W; Carneiro F; Gärtner F; Seruca R
Hum Mol Genet; 2009 Jul; 18(14):2599-608. PubMed ID: 19403558
[TBL] [Abstract][Full Text] [Related]
10. The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the β-catenin signaling pathway.
Munding J; Ziebarth W; Pox CP; Ladigan S; Reiser M; Hüppe D; Brand L; Schmiegel W; Tannapfel A; Reinacher-Schick AC
Carcinogenesis; 2012 Mar; 33(3):637-43. PubMed ID: 22198215
[TBL] [Abstract][Full Text] [Related]
11. Mesalamine and azathioprine modulate junctional complexes and restore epithelial barrier function in intestinal inflammation.
Khare V; Krnjic A; Frick A; Gmainer C; Asboth M; Jimenez K; Lang M; Baumgartner M; Evstatiev R; Gasche C
Sci Rep; 2019 Feb; 9(1):2842. PubMed ID: 30809073
[TBL] [Abstract][Full Text] [Related]
12. 5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-γ Signaling in the Intestinal Epithelium.
Cevallos SA; Lee JY; Velazquez EM; Foegeding NJ; Shelton CD; Tiffany CR; Parry BH; Stull-Lane AR; Olsan EE; Savage HP; Nguyen H; Ghanaat SS; Byndloss AJ; Agu IO; Tsolis RM; Byndloss MX; Bäumler AJ
mBio; 2021 Jan; 12(1):. PubMed ID: 33468700
[TBL] [Abstract][Full Text] [Related]
13. VE-cadherin N-glycosylation modified by N-acetylglucosaminyltransferase V regulates VE-cadherin-β-catenin interaction and monocyte adhesion.
Zhang L; Ma L; Li J; Lei J; Chen J; Yu C
Exp Physiol; 2021 Sep; 106(9):1869-1877. PubMed ID: 34117813
[TBL] [Abstract][Full Text] [Related]
14. Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine.
Naganuma M; Iwao Y; Ogata H; Inoue N; Funakoshi S; Yamamoto S; Nakamura Y; Ishii H; Hibi T
Inflamm Bowel Dis; 2001 Aug; 7(3):221-5. PubMed ID: 11515848
[TBL] [Abstract][Full Text] [Related]
15. Wnt/beta-catenin signaling down-regulates N-acetylglucosaminyltransferase III expression: the implications of two mutually exclusive pathways for regulation.
Xu Q; Akama R; Isaji T; Lu Y; Hashimoto H; Kariya Y; Fukuda T; Du Y; Gu J
J Biol Chem; 2011 Feb; 286(6):4310-8. PubMed ID: 21115490
[TBL] [Abstract][Full Text] [Related]
16. Mesalamine restores angiogenic balance in experimental ulcerative colitis by reducing expression of endostatin and angiostatin: novel molecular mechanism for therapeutic action of mesalamine.
Deng X; Tolstanova G; Khomenko T; Chen L; Tarnawski A; Szabo S; Sandor Z
J Pharmacol Exp Ther; 2009 Dec; 331(3):1071-8. PubMed ID: 19762547
[TBL] [Abstract][Full Text] [Related]
17. Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer.
Carvalho S; Catarino TA; Dias AM; Kato M; Almeida A; Hessling B; Figueiredo J; Gärtner F; Sanches JM; Ruppert T; Miyoshi E; Pierce M; Carneiro F; Kolarich D; Seruca R; Yamaguchi Y; Taniguchi N; Reis CA; Pinho SS
Oncogene; 2016 Mar; 35(13):1619-31. PubMed ID: 26189796
[TBL] [Abstract][Full Text] [Related]
18. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
[TBL] [Abstract][Full Text] [Related]
19. Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling.
Guo H; Nagy T; Pierce M
J Biol Chem; 2014 Nov; 289(45):31534-49. PubMed ID: 25274627
[TBL] [Abstract][Full Text] [Related]
20. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM
Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
